Clinical 0 8 0 8 B-cancer
stage 9 14 9 14 I-cancer
cT2 15 18 15 18 I-cancer
- 18 19 18 19 I-cancer
4aN0M0 19 25 19 25 I-cancer

ECOG 0 4 26 30 B-clinical_variable
PS 5 7 31 33 I-clinical_variable
0 8 9 34 35 B-lower_bound
, 9 10 35 36 O
1 11 12 37 38 B-upper_bound

Female 0 6 39 45 B-gender
subjects 7 15 46 54 I-gender
of 16 18 55 57 O
childbearing 19 31 58 70 O
potential 32 41 71 80 O
must 42 46 81 85 O
be 47 49 86 88 O
willing 50 57 89 96 B-contraception_consent
to 58 60 97 99 I-contraception_consent
use 61 64 100 103 I-contraception_consent
2 65 66 104 105 I-contraception_consent
methods 67 74 106 113 I-contraception_consent
of 75 77 114 116 I-contraception_consent
birth 78 83 117 122 I-contraception_consent
control 84 91 123 130 I-contraception_consent
, 91 92 130 131 O
be 93 95 132 134 O
surgically 96 106 135 145 O
sterile 107 114 146 153 O
, 114 115 153 154 O
or 116 118 155 157 O
abstain 119 126 158 165 O
from 127 131 166 170 O
heterosexual 132 144 171 183 O
intercourse 145 156 184 195 O
for 157 160 196 199 O
the 161 164 200 203 O
course 165 171 204 210 O
of 172 174 211 213 O
the 175 178 214 217 O
study 179 184 218 223 O
and 185 188 224 227 O
through 189 196 228 235 O
120 197 200 236 239 B-upper_bound
days 201 205 240 244 I-upper_bound
after 206 211 245 250 O
the 212 215 251 254 O
last 216 220 255 259 O
dose 221 225 260 264 O
of 226 228 265 267 O
study 229 234 268 273 O
medication 235 245 274 284 O

Female 0 6 285 291 B-gender
subjects 7 15 292 300 I-gender
of 16 18 301 303 O
childbearing 19 31 304 316 O
potential 32 41 317 326 O
must 42 46 327 331 O
have 47 51 332 336 O
a 52 53 337 338 O
negative 54 62 339 347 B-pregnancy
urine 63 68 348 353 I-pregnancy
or 69 71 354 356 I-pregnancy
serum 72 77 357 362 I-pregnancy
pregnancy 78 87 363 372 I-pregnancy
test 88 92 373 377 O
within 93 99 378 384 O
72 100 102 385 387 B-upper_bound
hours 103 108 388 393 I-upper_bound
prior 109 114 394 399 I-upper_bound
to 115 117 400 402 O
study 118 123 403 408 O
registration 124 136 409 421 O

Glomerular 0 10 422 432 B-clinical_variable
filtration 11 21 433 443 I-clinical_variable
rate 22 26 444 448 I-clinical_variable
( 27 28 449 450 I-clinical_variable
GFR 28 31 450 453 I-clinical_variable
) 31 32 453 454 I-clinical_variable
or 33 35 455 457 O
creatinine 36 46 458 468 B-clinical_variable
clearance 47 56 469 478 I-clinical_variable
( 57 58 479 480 I-clinical_variable
Ccr 58 61 480 483 I-clinical_variable
) 61 62 483 484 I-clinical_variable
≥ 63 64 485 486 O
50 65 67 487 489 B-lower_bound
mL 68 70 490 492 I-lower_bound
/ 70 71 492 493 I-lower_bound
min 71 74 493 496 I-lower_bound

Has 0 3 497 500 O
a 4 5 501 502 O
diagnosis 6 15 503 512 O
of 16 18 513 515 O
immunodeficiency 19 35 516 532 B-chronic_disease
or 36 38 533 535 O
received 39 47 536 544 O
systemic 48 56 545 553 B-treatment
steroid 57 64 554 561 I-treatment
therapy 65 72 562 569 I-treatment
or 73 75 570 572 O
any 76 79 573 576 O
other 80 85 577 582 O
form 86 90 583 587 O
of 91 93 588 590 O
immunosuppressive 94 111 591 608 B-treatment
therapy 112 119 609 616 I-treatment
within 120 126 617 623 O
7 127 128 624 625 B-upper_bound
days 129 133 626 630 I-upper_bound
prior 134 139 631 636 I-upper_bound
to 140 142 637 639 O
study 143 148 640 645 O
registration 149 161 646 658 O

Has 0 3 659 662 O
a 4 5 663 664 O
history 6 13 665 672 O
or 14 16 673 675 O
current 17 24 676 683 O
evidence 25 33 684 692 O
of 34 36 693 695 O
any 37 40 696 699 O
condition 41 50 700 709 O
, 50 51 709 710 O
therapy 52 59 711 718 B-treatment
, 59 60 718 719 O
or 61 63 720 722 O
laboratory 64 74 723 733 O
abnormality 75 86 734 745 O
that 87 91 746 750 O
might 92 97 751 756 O
confound 98 106 757 765 O
the 107 110 766 769 O
results 111 118 770 777 O
of 119 121 778 780 O
the 122 125 781 784 O
trial 126 131 785 790 O
, 131 132 790 791 O
interfere 133 142 792 801 O
with 143 147 802 806 O
the 148 151 807 810 O
subject 152 159 811 818 O
's 159 161 818 820 O
participation 162 175 821 834 O
for 176 179 835 838 O
the 180 183 839 842 O
full 184 188 843 847 O
duration 189 197 848 856 O
of 198 200 857 859 O
the 201 204 860 863 O
trial 205 210 864 869 O
, 210 211 869 870 O
or 212 214 871 873 O
is 215 217 874 876 O
not 218 221 877 880 O
in 222 224 881 883 O
the 225 228 884 887 O
best 229 233 888 892 O
interest 234 242 893 901 O
of 243 245 902 904 O
the 246 249 905 908 O
subject 250 257 909 916 O
to 258 260 917 919 O
participate 261 272 920 931 O
, 272 273 931 932 O
in 274 276 933 935 O
the 277 280 936 939 O
opinion 281 288 940 947 O
of 289 291 948 950 O
the 292 295 951 954 O
treating 296 304 955 963 O
investigator 305 317 964 976 O

Has 0 3 977 980 O
a 4 5 981 982 O
known 6 11 983 988 O
additional 12 22 989 999 O
malignancy 23 33 1000 1010 B-cancer
that 34 38 1011 1015 O
is 39 41 1016 1018 O
progressing 42 53 1019 1030 O
or 54 56 1031 1033 O
required 57 65 1034 1042 O
treatment 66 75 1043 1052 B-treatment
≤ 76 77 1053 1054 O
48 78 80 1055 1057 B-upper_bound
months 81 87 1058 1064 I-upper_bound
of 88 90 1065 1067 O
study 91 96 1068 1073 O
registration 97 109 1074 1086 O

Has 0 3 1087 1090 O
a 4 5 1091 1092 O
known 6 11 1093 1098 O
history 12 19 1099 1106 O
of 20 22 1107 1109 O
Human 23 28 1110 1115 B-chronic_disease
Immunodeficiency 29 45 1116 1132 I-chronic_disease
Virus 46 51 1133 1138 I-chronic_disease
( 52 53 1139 1140 O
HIV 53 56 1140 1143 B-chronic_disease
) 56 57 1143 1144 O
( 58 59 1145 1146 O
HIV 59 62 1146 1149 O
1/2 63 66 1150 1153 O
antibodies 67 77 1154 1164 O
) 77 78 1164 1165 O

Has 0 3 1166 1169 O
abdomino 4 12 1170 1178 B-clinical_variable
- 12 13 1178 1179 I-clinical_variable
pelvic 13 19 1179 1185 I-clinical_variable
short 20 25 1186 1191 I-clinical_variable
axis 26 30 1192 1196 I-clinical_variable
lymph 31 36 1197 1202 I-clinical_variable
node 37 41 1203 1207 I-clinical_variable
of 42 44 1208 1210 O
≥15 45 48 1211 1214 O
mm 48 50 1214 1216 I-lower_bound
without 51 58 1217 1224 O
biopsy 59 65 1225 1231 B-treatment

Has 0 3 1232 1235 O
an 4 6 1236 1238 O
active 7 13 1239 1245 O
autoimmune 14 24 1246 1256 B-chronic_disease
disease 25 32 1257 1264 I-chronic_disease
requiring 33 42 1265 1274 O
systemic 43 51 1275 1283 B-treatment
treatment 52 61 1284 1293 I-treatment
within 62 68 1294 1300 O
the 69 72 1301 1304 O
past 73 77 1305 1309 B-upper_bound
3 78 79 1310 1311 I-upper_bound
months 80 86 1312 1318 I-upper_bound
or 87 89 1319 1321 O
a 90 91 1322 1323 O
documented 92 102 1324 1334 O
history 103 110 1335 1342 O
of 111 113 1343 1345 O
clinically 114 124 1346 1356 O
severe 125 131 1357 1363 O
autoimmune 132 142 1364 1374 O
disease 143 150 1375 1382 O
, 150 151 1382 1383 O
or 152 154 1384 1386 O
a 155 156 1387 1388 O
syndrome 157 165 1389 1397 O
that 166 170 1398 1402 O
requires 171 179 1403 1411 O
systemic 180 188 1412 1420 B-treatment
steroids 189 197 1421 1429 I-treatment
or 198 200 1430 1432 O
immunosuppressive 201 218 1433 1450 B-treatment
agents 219 225 1451 1457 I-treatment

Has 0 3 1458 1461 O
an 4 6 1462 1464 O
active 7 13 1465 1471 B-chronic_disease
infection 14 23 1472 1481 I-chronic_disease
requiring 24 33 1482 1491 O
systemic 34 42 1492 1500 B-treatment
therapy 43 50 1501 1508 I-treatment

Has 0 3 1509 1512 O
had 4 7 1513 1516 O
a 8 9 1517 1518 O
prior 10 15 1519 1524 O
monoclonal 16 26 1525 1535 O
antibody 27 35 1536 1544 O
≤ 36 37 1545 1546 O
28 38 40 1547 1549 B-upper_bound
days 41 45 1550 1554 I-upper_bound
prior 46 51 1555 1560 I-upper_bound
to 52 54 1561 1563 O
study 55 60 1564 1569 O
registration 61 73 1570 1582 O
or 74 76 1583 1585 O
who 77 80 1586 1589 O
has 81 84 1590 1593 O
not 85 88 1594 1597 O
recovered 89 98 1598 1607 O
( 99 100 1608 1609 O
i.e. 100 104 1609 1613 O
, 104 105 1613 1614 O
≤ 106 107 1615 1616 O
Grade 108 113 1617 1622 B-upper_bound
1 114 115 1623 1624 I-upper_bound
or 116 118 1625 1627 O
at 119 121 1628 1630 O
baseline 122 130 1631 1639 O
) 130 131 1639 1640 O
from 132 136 1641 1645 O
adverse 137 144 1646 1653 O
events 145 151 1654 1660 O
due 152 155 1661 1664 O
to 156 158 1665 1667 O
agents 159 165 1668 1674 O
administered 166 178 1675 1687 O
more 179 183 1688 1692 O
than 184 188 1693 1697 O
28 189 191 1698 1700 O
days 192 196 1701 1705 O
earlier 197 204 1706 1713 O

Has 0 3 1714 1717 O
had 4 7 1718 1721 O
prior 8 13 1722 1727 B-treatment
chemotherapy 14 26 1728 1740 I-treatment
, 26 27 1740 1741 O
targeted 28 36 1742 1750 O
small 37 42 1751 1756 O
molecule 43 51 1757 1765 B-treatment
therapy 52 59 1766 1773 I-treatment
, 59 60 1773 1774 O
or 61 63 1775 1777 O
radiation 64 73 1778 1787 B-treatment
therapy 74 81 1788 1795 I-treatment
for 82 85 1796 1799 O
urothelial 86 96 1800 1810 B-cancer
carcinoma 97 106 1811 1820 I-cancer

Has 0 3 1821 1824 O
known 4 9 1825 1830 O
active 10 16 1831 1837 O
Hepatitis 17 26 1838 1847 B-chronic_disease
B 27 28 1848 1849 I-chronic_disease
( 29 30 1850 1851 O
e.g. 30 34 1851 1855 O
, 34 35 1855 1856 O
HBsAg 36 41 1857 1862 B-clinical_variable
reactive 42 50 1863 1871 O
) 50 51 1871 1872 O
or 52 54 1873 1875 O
Hepatitis 55 64 1876 1885 B-chronic_disease
C 65 66 1886 1887 I-chronic_disease
( 67 68 1888 1889 O
e.g. 68 72 1889 1893 O
, 72 73 1893 1894 O
HCV 74 77 1895 1898 B-clinical_variable
RNA 78 81 1899 1902 I-clinical_variable
[ 82 83 1903 1904 O
qualitative 83 94 1904 1915 O
] 94 95 1915 1916 O
is 96 98 1917 1919 O
detected 99 107 1920 1928 O
) 107 108 1928 1929 O

Has 0 3 1930 1933 O
known 4 9 1934 1939 O
active 10 16 1940 1946 O
central 17 24 1947 1954 B-cancer
nervous 25 32 1955 1962 I-cancer
system 33 39 1963 1969 I-cancer
( 40 41 1970 1971 I-cancer
CNS 41 44 1971 1974 I-cancer
) 44 45 1974 1975 I-cancer
metastases 46 56 1976 1986 I-cancer
and/or 57 63 1987 1993 O
carcinomatous 64 77 1994 2007 B-cancer
meningitis 78 88 2008 2018 I-cancer

Has 0 3 2019 2022 O
known 4 9 2023 2028 O
evidence 10 18 2029 2037 O
of 19 21 2038 2040 O
interstitial 22 34 2041 2053 O
lung 35 39 2054 2058 B-chronic_disease
disease 40 47 2059 2066 I-chronic_disease
or 48 50 2067 2069 O
active 51 57 2070 2076 O
, 57 58 2076 2077 O
non 59 62 2078 2081 O
- 62 63 2081 2082 O
infectious 63 73 2082 2092 O
pneumonitis 74 85 2093 2104 B-chronic_disease

Has 0 3 2105 2108 O
known 4 9 2109 2114 O
psychiatric 10 21 2115 2126 B-chronic_disease
or 22 24 2127 2129 O
substance 25 34 2130 2139 O
abuse 35 40 2140 2145 O
disorders 41 50 2146 2155 O
that 51 55 2156 2160 O
would 56 61 2161 2166 O
interfere 62 71 2167 2176 O
with 72 76 2177 2181 O
cooperation 77 88 2182 2193 O
with 89 93 2194 2198 O
the 94 97 2199 2202 O
requirements 98 110 2203 2215 O
of 111 113 2216 2218 O
the 114 117 2219 2222 O
trial 118 123 2223 2228 O

Has 0 3 2229 2232 O
received 4 12 2233 2241 O
a 13 14 2242 2243 O
live 15 19 2244 2248 B-treatment
vaccine 20 27 2249 2256 I-treatment
within 28 34 2257 2263 O
30 35 37 2264 2266 B-upper_bound
days 38 42 2267 2271 I-upper_bound
prior 43 48 2272 2277 I-upper_bound
to 49 51 2278 2280 O
the 52 55 2281 2284 O
first 56 61 2285 2290 O
dose 62 66 2291 2295 O
of 67 69 2296 2298 O
trial 70 75 2299 2304 B-treatment
treatment 76 85 2305 2314 I-treatment

Has 0 3 2315 2318 O
received 4 12 2319 2327 O
prior 13 18 2328 2333 B-treatment
therapy 19 26 2334 2341 I-treatment
with 27 31 2342 2346 I-treatment
an 32 34 2347 2349 I-treatment
anti 35 39 2350 2354 I-treatment
- 39 40 2354 2355 I-treatment
PD-1 40 44 2355 2359 I-treatment
, 44 45 2359 2360 I-treatment
anti 46 50 2361 2365 I-treatment
- 50 51 2365 2366 I-treatment
PD 51 53 2366 2368 I-treatment
- 53 54 2368 2369 I-treatment
L1 54 56 2369 2371 I-treatment
, 56 57 2371 2372 I-treatment
anti 58 62 2373 2377 I-treatment
- 62 63 2377 2378 I-treatment
PD 63 65 2378 2380 I-treatment
- 65 66 2380 2381 I-treatment
L2 66 68 2381 2383 I-treatment
, 68 69 2383 2384 I-treatment
anti 70 74 2385 2389 I-treatment
- 74 75 2389 2390 I-treatment
CD137 75 80 2390 2395 I-treatment
, 80 81 2395 2396 O
or 82 84 2397 2399 O
anti 85 89 2400 2404 B-treatment
- 89 90 2404 2405 I-treatment
cytotoxic 90 99 2405 2414 I-treatment
T 100 101 2415 2416 I-treatment
- 101 102 2416 2417 I-treatment
lymphocyte 102 112 2417 2427 I-treatment
- 112 113 2427 2428 I-treatment
associated 113 123 2428 2438 I-treatment
antigen-4 124 133 2439 2448 I-treatment
( 134 135 2449 2450 O
CTLA-4 135 141 2450 2456 B-treatment
) 141 142 2456 2457 I-treatment
antibody 143 151 2458 2466 I-treatment
( 152 153 2467 2468 O
including 153 162 2468 2477 O
ipilimumab 163 173 2478 2488 B-treatment
or 174 176 2489 2491 O
any 177 180 2492 2495 O
other 181 186 2496 2501 O
antibody 187 195 2502 2510 O
or 196 198 2511 2513 O
drug 199 203 2514 2518 O
specifically 204 216 2519 2531 O
targeting 217 226 2532 2541 O
T 227 228 2542 2543 O
- 228 229 2543 2544 O
cell 229 233 2544 2548 O
co 234 236 2549 2551 O
- 236 237 2551 2552 O
stimulation 237 248 2552 2563 O
or 249 251 2564 2566 O
checkpoint 252 262 2567 2577 O
pathways 263 271 2578 2586 O
) 271 272 2586 2587 O

Has 0 3 2588 2591 O
received 4 12 2592 2600 O
therapy 13 20 2601 2608 B-treatment
with 21 25 2609 2613 I-treatment
hematopoietic 26 39 2614 2627 I-treatment
growth 40 46 2628 2634 I-treatment
factor 47 53 2635 2641 I-treatment
such 54 58 2642 2646 O
as 59 61 2647 2649 O
G 62 63 2650 2651 B-treatment
- 63 64 2651 2652 I-treatment
CSF 64 67 2652 2655 I-treatment
or 68 70 2656 2658 O
GM 71 73 2659 2661 B-treatment
- 73 74 2661 2662 I-treatment
CSF 74 77 2662 2665 I-treatment
in 78 80 2666 2668 O
the 81 84 2669 2672 O
14 85 87 2673 2675 B-upper_bound
days 88 92 2676 2680 I-upper_bound
prior 93 98 2681 2686 I-upper_bound
to 99 101 2687 2689 O
registration 102 114 2690 2702 O

Have 0 4 2703 2707 O
a 5 6 2708 2709 O
surgical 7 15 2710 2718 O
evaluation 16 26 2719 2729 O
that 27 31 2730 2734 O
documents 32 41 2735 2744 O
the 42 45 2745 2748 O
plan 46 50 2749 2753 O
for 51 54 2754 2757 O
multimodality 55 68 2758 2771 B-treatment
therapy 69 76 2772 2779 I-treatment
with 77 81 2780 2784 O
a 82 83 2785 2786 O
consolidative 84 97 2787 2800 O
radical 98 105 2801 2808 O
cystectomy 106 116 2809 2819 B-treatment
or 117 119 2820 2822 O
nephroureterectomy 120 138 2823 2841 B-treatment

Have 0 4 2842 2846 O
an 5 7 2847 2849 O
archived 8 16 2850 2858 O
tumor 17 22 2859 2864 B-cancer
block 23 28 2865 2870 O
available 29 38 2871 2880 O
to 39 41 2881 2883 O
submit 42 48 2884 2890 O
unstained 49 58 2891 2900 O
slides 59 65 2901 2907 O
for 66 69 2908 2911 O
PD 70 72 2912 2914 O
- 72 73 2914 2915 O
L1 73 75 2915 2917 O
expression 76 86 2918 2928 O
, 86 87 2928 2929 O
basal 88 93 2930 2935 O
and 94 97 2936 2939 O
luminal 98 105 2940 2947 O
subtype 106 113 2948 2955 O
analysis 114 122 2956 2964 O

Hearing 0 7 2965 2972 B-clinical_variable
impaired 8 16 2973 2981 I-clinical_variable
≤ 17 18 2982 2983 O
grade 19 24 2984 2989 B-upper_bound
1 25 26 2990 2991 I-upper_bound
( 27 28 2992 2993 O
may 28 31 2993 2996 O
or 32 34 2997 2999 O
may 35 38 3000 3003 O
not 39 42 3004 3007 O
be 43 45 3008 3010 O
enrolled 46 54 3011 3019 O
in 55 57 3020 3022 O
a 58 59 3023 3024 O
monitoring 60 70 3025 3035 O
program 71 78 3036 3043 O
) 78 79 3043 3044 O

Hearing 0 7 3045 3052 B-chronic_disease
impaired 8 16 3053 3061 I-chronic_disease
≥grade 17 23 3062 3068 O
2 24 25 3069 3070 I-lower_bound
as 26 28 3071 3073 O
assessed 29 37 3074 3082 O
by 38 40 3083 3085 O
treating 41 49 3086 3094 O
physician 50 59 3095 3104 O
( 60 61 3105 3106 O
may 61 64 3106 3109 O
or 65 67 3110 3112 O
may 68 71 3113 3116 O
not 72 75 3117 3120 O
be 76 78 3121 3123 O
enrolled 79 87 3124 3132 O
in 88 90 3133 3135 O
a 91 92 3136 3137 O
monitoring 93 103 3138 3148 O
program 104 111 3149 3156 O
) 111 112 3156 3157 O

Histology 0 9 3158 3167 O
must 10 14 3168 3172 O
be 15 17 3173 3175 O
urothelial 18 28 3176 3186 B-cancer
carcinoma 29 38 3187 3196 I-cancer
( 39 40 3197 3198 O
transitional 40 52 3198 3210 B-cancer
cell 53 57 3211 3215 I-cancer
carcinoma 58 67 3216 3225 I-cancer
) 67 68 3225 3226 O
or 69 71 3227 3229 O
urothelial 72 82 3230 3240 O
carcinoma 83 92 3241 3250 O
with 93 97 3251 3255 O
mixed 98 103 3256 3261 O
histology 104 113 3262 3271 O
/ 113 114 3271 3272 O
features 114 122 3272 3280 O

Is 0 2 3281 3283 O
currently 3 12 3284 3293 O
participating 13 26 3294 3307 O
in 27 29 3308 3310 O
or 30 32 3311 3313 O
has 33 36 3314 3317 O
participated 37 49 3318 3330 O
in 50 52 3331 3333 O
a 53 54 3334 3335 O
study 55 60 3336 3341 O
of 61 63 3342 3344 O
an 64 66 3345 3347 O
investigational 67 82 3348 3363 B-treatment
agent 83 88 3364 3369 I-treatment
or 89 91 3370 3372 O
using 92 97 3373 3378 O
an 98 100 3379 3381 O
investigational 101 116 3382 3397 B-treatment
device 117 123 3398 3404 I-treatment
within 124 130 3405 3411 O
28 131 133 3412 3414 B-upper_bound
days 134 138 3415 3419 I-upper_bound
prior 139 144 3420 3425 I-upper_bound
to 145 147 3426 3428 O
study 148 153 3429 3434 O
registration 154 166 3435 3447 O

Is 0 2 3448 3450 O
pregnant 3 11 3451 3459 B-pregnancy

Male 0 4 3460 3464 B-gender
subjects 5 13 3465 3473 I-gender
must 14 18 3474 3478 O
agree 19 24 3479 3484 B-contraception_consent
to 25 27 3485 3487 I-contraception_consent
use 28 31 3488 3491 I-contraception_consent
a 32 33 3492 3493 I-contraception_consent
barrier 34 41 3494 3501 I-contraception_consent
method 42 48 3502 3508 I-contraception_consent
of 49 51 3509 3511 I-contraception_consent
male 52 56 3512 3516 I-contraception_consent
contraception 57 70 3517 3530 I-contraception_consent
starting 71 79 3531 3539 O
with 80 84 3540 3544 O
the 85 88 3545 3548 O
first 89 94 3549 3554 O
dose 95 99 3555 3559 O
of 100 102 3560 3562 O
study 103 108 3563 3568 O
therapy 109 116 3569 3576 B-treatment
and 117 120 3577 3580 O
through 121 128 3581 3588 O
120 129 132 3589 3592 B-lower_bound
days 133 137 3593 3597 I-lower_bound
after 138 143 3598 3603 I-lower_bound
the 144 147 3604 3607 O
last 148 152 3608 3612 O
dose 153 157 3613 3617 O
of 158 160 3618 3620 O
study 161 166 3621 3626 O
therapy 167 174 3627 3634 O

Minimum 0 7 3635 3642 O
guidance 8 16 3643 3651 O
on 17 19 3652 3654 O
surgical 20 28 3655 3663 O
intent 29 35 3664 3670 O
includes 36 44 3671 3679 O
subjects 45 53 3680 3688 O
who 54 57 3689 3692 O
do 58 60 3693 3695 O
not 61 64 3696 3699 O
have 65 69 3700 3704 O
significant 70 81 3705 3716 O
cardiovascular 82 96 3717 3731 B-chronic_disease
disease 97 104 3732 3739 I-chronic_disease
such 105 109 3740 3744 O
as 110 112 3745 3747 O
NHYA 113 117 3748 3752 O
class 118 123 3753 3758 B-chronic_disease
III 124 127 3759 3762 I-chronic_disease
or 128 130 3763 3765 I-chronic_disease
IV 131 133 3766 3768 I-chronic_disease
heart 134 139 3769 3774 I-chronic_disease
failure 140 147 3775 3782 I-chronic_disease
, 147 148 3782 3783 O
unstable 149 157 3784 3792 B-chronic_disease
arrhythmias 158 169 3793 3804 I-chronic_disease
or 170 172 3805 3807 O
angina 173 179 3808 3814 B-chronic_disease
, 179 180 3814 3815 O
active 181 187 3816 3822 B-chronic_disease
CAD 188 191 3823 3826 I-chronic_disease
, 191 192 3826 3827 O
and/or 193 199 3828 3834 O
EF<25 200 205 3835 3840 B-clinical_variable
% 205 206 3840 3841 I-upper_bound

Over 0 4 3842 3846 O
18 5 7 3847 3849 B-lower_bound
years 8 13 3850 3855 I-lower_bound
of 14 16 3856 3858 O
age 17 20 3859 3862 B-age
on 21 23 3863 3865 O
day 24 27 3866 3869 O
of 28 30 3870 3872 O
signing 31 38 3873 3880 O
informed 39 47 3881 3889 O
consent 48 55 3890 3897 O

Peripheral 0 10 3898 3908 B-chronic_disease
neuropathy 11 21 3909 3919 I-chronic_disease
of 22 24 3920 3922 O
Grade 25 30 3923 3928 B-lower_bound
2 31 32 3929 3930 I-lower_bound
- 32 33 3930 3931 O
4 33 34 3931 3932 B-upper_bound

Peripheral 0 10 3933 3943 B-clinical_variable
neuropathy 11 21 3944 3954 I-clinical_variable
≤grade 22 28 3955 3961 O
1 29 30 3962 3963 I-upper_bound

Subjects 0 8 3964 3972 O
on 9 11 3973 3975 O
full 12 16 3976 3980 O
dose 17 21 3981 3985 O
anticoagulants 22 36 3986 4000 B-treatment
must 37 41 4001 4005 O
be 42 44 4006 4008 O
on 45 47 4009 4011 O
a 48 49 4012 4013 O
stable 50 56 4014 4020 O
regimen 57 64 4021 4028 O
of 65 67 4029 4031 O
warfarin 68 76 4032 4040 B-treatment
or 77 79 4041 4043 O
low 80 83 4044 4047 B-treatment
molecular 84 93 4048 4057 I-treatment
weight 94 100 4058 4064 I-treatment
heparin 101 108 4065 4072 I-treatment
( 109 110 4073 4074 I-treatment
LMWH 110 114 4074 4078 I-treatment
) 114 115 4078 4079 I-treatment
for 116 119 4080 4083 O
at 120 122 4084 4086 O
least 123 128 4087 4092 O
two 129 132 4093 4096 B-lower_bound
weeks 133 138 4097 4102 I-lower_bound

The 0 3 4103 4106 O
cisplatin 4 13 4107 4116 B-treatment
dose 14 18 4117 4121 O
will 19 23 4122 4126 O
be 24 26 4127 4129 O
split 27 32 4130 4135 O
over 33 37 4136 4140 O
two 38 41 4141 4144 B-upper_bound
days 42 46 4145 4149 I-upper_bound
for 47 50 4150 4153 O
values 51 57 4154 4160 O
between 58 65 4161 4168 O
50 66 68 4169 4171 B-lower_bound
- 68 69 4171 4172 O
59 69 71 4172 4174 B-upper_bound
mL 72 74 4175 4177 I-upper_bound
/ 74 75 4177 4178 I-upper_bound
min 75 78 4178 4181 I-upper_bound

starting 0 8 4182 4190 O
with 9 13 4191 4195 O
the 14 17 4196 4199 O
pre 18 21 4200 4203 O
- 21 22 4203 4204 O
screening 22 31 4204 4213 O
or 32 34 4214 4216 O
screening 35 44 4217 4226 O
visit 45 50 4227 4232 O
through 51 58 4233 4240 O
120 59 62 4241 4244 B-upper_bound
days 63 67 4245 4249 I-upper_bound
after 68 73 4250 4255 I-upper_bound
the 74 77 4256 4259 O
last 78 82 4260 4264 O
dose 83 87 4265 4269 O
of 88 90 4270 4272 O
trial 91 96 4273 4278 B-treatment
treatment 97 106 4279 4288 I-treatment

